# ARPA-H Tests Heart Failure AI

ARPA-H is testing ADVOCATE, a patient-facing AI system designed to monitor people with heart failure, support triage and diagnosis, and potentially manage some treatments between clinician visits. ARPA-H is working with FDA on evaluation and regulatory pathways and has stated a goal of seeking market authorization within two years. The signal identifies no contract award, solicitation, budget, or vendor, so it points to an emerging federal health-AI research and regulatory effort rather than an active bid opportunity.

- The work centers on clinical evaluation and FDA authorization for AI that could perform patient monitoring and care-management functions between visits.
- Health-AI contractors can assess whether their capabilities in clinical validation, digital health, and regulatory support align with the program’s stated direction; no specific procurement vehicle or requirement is identified.
- The effort highlights the importance of demonstrating safety and effectiveness for patient-facing AI intended to inform or manage care. As Haider Warraich noted, “There's no real generative AI technology or agentic AI technology that has ever received FDA authorization.”

**Jurisdictions:** federal
**Industries:** Healthcare, Information Technology
**Topics:** Artificial Intelligence, Regulatory Compliance
**Published:** October 14, 2026

### Government Entities
- Advanced Research Projects Agency for Health (ARPA-H)
- Food and Drug Administration (FDA)
- Digital Health Center of Excellence

### Key Quotes
> There's no real generative AI technology or agentic AI technology that has ever received FDA authorization.
> — Dr. Haider Warraich, Program Manager at ARPA-H

### Sources
- [
        If technology can help collect information, can it also be trusted to act on it? - Federal News Network](https://federalnewsnetwork.com/technology-main/2026/10/if-technology-can-help-collect-information-can-it-also-be-trusted-to-act-on-it) - Federal News Network